Oncternal Therapeutics, Inc.·4

Jan 31, 4:00 PM ET

Yazji Salim 4

4 · Oncternal Therapeutics, Inc. · Filed Jan 31, 2022

Insider Transaction Report

Form 4
Period: 2022-01-27
Yazji Salim
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-01-27$1.69/sh+10,000$16,90067,137 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION